Katie Couric shares what she wishes she knew about colon cancer before her husband died at 42 years old [Business Insider]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Business Insider
He was 41 years old and his symptoms like fatigue didn't stand out as signs of cancer. Detecting colon cancer early is key to treatment, and innovations with AI and blood tests can help. When Katie Couric's husband, Jay Monahan, was diagnosed with colon cancer at 41 years old it was a complete shock. By the time he was diagnosed it was already stage 4. He died 9 months later, weeks after his 42nd birthday. "Colon cancer didn't even cross our minds. He of course had symptoms, and in hindsight, I wish we had known what they were," Couric told Business Insider. Monahan had been tired, but that was understandable as a busy lawyer and legal analyst for NBC News, and a parent to their two daughters. That fatigue, and some digestive changes, were vague symptoms of his illness. They're common early signs of colon cancer that can be easy to miss. At the time of his diagnosis, in 1997, the recommended age for colonoscopy was 50. Today, it's 45 — changed in 2021 in a response to a con
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- November $10B+ M&A Deals Set Q4 Up To Outpace Prior Quarter [Seeking Alpha]Seeking Alpha
- Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS [Yahoo! Finance]Yahoo! Finance
- Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCSBusiness Wire
- Grail: Downgraded From Speculative Buy To Hold As The Stock Price Appreciated Faster Than Expected [Seeking Alpha]Seeking Alpha
- Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Stifel Nicolaus.MarketBeat
EXAS
Earnings
- 11/3/25 - Beat
EXAS
Sec Filings
- 12/5/25 - Form SCHEDULE
- 11/26/25 - Form DEFA14A
- 11/24/25 - Form DEFA14A
- EXAS's page on the SEC website